WGFR ve gangliyozid N-glikolil GM3(NeuGcGM3) ifade eden tümörlerin tedavisine yönelik farmasötik bileşimler
Mevcut buluş habis tümörlerin tedavisine yönelik farmasötik bileşimler ile ilgilidir. Özellikle EGFR ve GM3 N-glikolil gangliyozid ifade eden bu tümörler, bu hedeflere karşı ayrı terapiler ile üretilen terapötik etkiyi arttırmayı hedefler. Buluşun bu farmasötik bileşimleri hedeflerin her birine karş...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | tur |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | AMPARO EMILIA MACÍAS, ABRAHAM MARIA DEL CARMEN BARROSO, ALVAREZ ADRIANA CARR, PEREZ KALET LEÓN, MONZÓN RANCÉS BLANCO, SANTANA JOSÉ ENRIQUE MONTERO, CASIMIRO ADYS GONZÁLEZ, PALOMO |
| description | Mevcut buluş habis tümörlerin tedavisine yönelik farmasötik bileşimler ile ilgilidir. Özellikle EGFR ve GM3 N-glikolil gangliyozid ifade eden bu tümörler, bu hedeflere karşı ayrı terapiler ile üretilen terapötik etkiyi arttırmayı hedefler. Buluşun bu farmasötik bileşimleri hedeflerin her birine karşı antikorlar ve/veya aşılar içerir. Ek olarak mevcut buluş bileşimlerinin uygulanmasına yönelik yöntemler ile ilgilidir.
The present invention relates to pharmaceutical compositions for the treatment of malignant tumors. Particularly those tumors that express EGFR and GM3 N- glycolyl ganglioside targets to enhance the therapeutic effect produced by separated therapies against these targets. The pharmaceutical compositions of the invention include antibodies and/or vaccines against each of the targets. Additionally the present invention relates to methods for applying the compositions of the invention. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_TR201816232TT4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>TR201816232TT4</sourcerecordid><originalsourceid>FETCH-epo_espacenet_TR201816232TT43</originalsourceid><addsrcrecordid>eNrjZCgId3cLUihLVUhPzEvPyazMr8pMUfDTBTKz83MycxTcfY01_FJL3ZOBDE2FzLTElFSF1JTUPIWSw3tyD28rykktygRyUlMSyzKLM_NSFSoPb8tLBepWSEssyk0sPrytBMhOysxJPTo_MxeomoeBNS0xpziVF0pzMyi7uYY4e-imFuTHpxYXJCan5qWWxIcEGRkYWhiaGRkbhYSYGBOnCgAEiUbB</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>WGFR ve gangliyozid N-glikolil GM3(NeuGcGM3) ifade eden tümörlerin tedavisine yönelik farmasötik bileşimler</title><source>esp@cenet</source><creator>AMPARO EMILIA MACÍAS, ABRAHAM ; MARIA DEL CARMEN BARROSO, ALVAREZ ; ADRIANA CARR, PEREZ ; KALET LEÓN, MONZÓN ; RANCÉS BLANCO, SANTANA ; JOSÉ ENRIQUE MONTERO, CASIMIRO ; ADYS GONZÁLEZ, PALOMO</creator><creatorcontrib>AMPARO EMILIA MACÍAS, ABRAHAM ; MARIA DEL CARMEN BARROSO, ALVAREZ ; ADRIANA CARR, PEREZ ; KALET LEÓN, MONZÓN ; RANCÉS BLANCO, SANTANA ; JOSÉ ENRIQUE MONTERO, CASIMIRO ; ADYS GONZÁLEZ, PALOMO</creatorcontrib><description>Mevcut buluş habis tümörlerin tedavisine yönelik farmasötik bileşimler ile ilgilidir. Özellikle EGFR ve GM3 N-glikolil gangliyozid ifade eden bu tümörler, bu hedeflere karşı ayrı terapiler ile üretilen terapötik etkiyi arttırmayı hedefler. Buluşun bu farmasötik bileşimleri hedeflerin her birine karşı antikorlar ve/veya aşılar içerir. Ek olarak mevcut buluş bileşimlerinin uygulanmasına yönelik yöntemler ile ilgilidir.
The present invention relates to pharmaceutical compositions for the treatment of malignant tumors. Particularly those tumors that express EGFR and GM3 N- glycolyl ganglioside targets to enhance the therapeutic effect produced by separated therapies against these targets. The pharmaceutical compositions of the invention include antibodies and/or vaccines against each of the targets. Additionally the present invention relates to methods for applying the compositions of the invention.</description><language>tur</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181121&DB=EPODOC&CC=TR&NR=201816232T4$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76419</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181121&DB=EPODOC&CC=TR&NR=201816232T4$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>AMPARO EMILIA MACÍAS, ABRAHAM</creatorcontrib><creatorcontrib>MARIA DEL CARMEN BARROSO, ALVAREZ</creatorcontrib><creatorcontrib>ADRIANA CARR, PEREZ</creatorcontrib><creatorcontrib>KALET LEÓN, MONZÓN</creatorcontrib><creatorcontrib>RANCÉS BLANCO, SANTANA</creatorcontrib><creatorcontrib>JOSÉ ENRIQUE MONTERO, CASIMIRO</creatorcontrib><creatorcontrib>ADYS GONZÁLEZ, PALOMO</creatorcontrib><title>WGFR ve gangliyozid N-glikolil GM3(NeuGcGM3) ifade eden tümörlerin tedavisine yönelik farmasötik bileşimler</title><description>Mevcut buluş habis tümörlerin tedavisine yönelik farmasötik bileşimler ile ilgilidir. Özellikle EGFR ve GM3 N-glikolil gangliyozid ifade eden bu tümörler, bu hedeflere karşı ayrı terapiler ile üretilen terapötik etkiyi arttırmayı hedefler. Buluşun bu farmasötik bileşimleri hedeflerin her birine karşı antikorlar ve/veya aşılar içerir. Ek olarak mevcut buluş bileşimlerinin uygulanmasına yönelik yöntemler ile ilgilidir.
The present invention relates to pharmaceutical compositions for the treatment of malignant tumors. Particularly those tumors that express EGFR and GM3 N- glycolyl ganglioside targets to enhance the therapeutic effect produced by separated therapies against these targets. The pharmaceutical compositions of the invention include antibodies and/or vaccines against each of the targets. Additionally the present invention relates to methods for applying the compositions of the invention.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZCgId3cLUihLVUhPzEvPyazMr8pMUfDTBTKz83MycxTcfY01_FJL3ZOBDE2FzLTElFSF1JTUPIWSw3tyD28rykktygRyUlMSyzKLM_NSFSoPb8tLBepWSEssyk0sPrytBMhOysxJPTo_MxeomoeBNS0xpziVF0pzMyi7uYY4e-imFuTHpxYXJCan5qWWxIcEGRkYWhiaGRkbhYSYGBOnCgAEiUbB</recordid><startdate>20181121</startdate><enddate>20181121</enddate><creator>AMPARO EMILIA MACÍAS, ABRAHAM</creator><creator>MARIA DEL CARMEN BARROSO, ALVAREZ</creator><creator>ADRIANA CARR, PEREZ</creator><creator>KALET LEÓN, MONZÓN</creator><creator>RANCÉS BLANCO, SANTANA</creator><creator>JOSÉ ENRIQUE MONTERO, CASIMIRO</creator><creator>ADYS GONZÁLEZ, PALOMO</creator><scope>EVB</scope></search><sort><creationdate>20181121</creationdate><title>WGFR ve gangliyozid N-glikolil GM3(NeuGcGM3) ifade eden tümörlerin tedavisine yönelik farmasötik bileşimler</title><author>AMPARO EMILIA MACÍAS, ABRAHAM ; MARIA DEL CARMEN BARROSO, ALVAREZ ; ADRIANA CARR, PEREZ ; KALET LEÓN, MONZÓN ; RANCÉS BLANCO, SANTANA ; JOSÉ ENRIQUE MONTERO, CASIMIRO ; ADYS GONZÁLEZ, PALOMO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_TR201816232TT43</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>tur</language><creationdate>2018</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>AMPARO EMILIA MACÍAS, ABRAHAM</creatorcontrib><creatorcontrib>MARIA DEL CARMEN BARROSO, ALVAREZ</creatorcontrib><creatorcontrib>ADRIANA CARR, PEREZ</creatorcontrib><creatorcontrib>KALET LEÓN, MONZÓN</creatorcontrib><creatorcontrib>RANCÉS BLANCO, SANTANA</creatorcontrib><creatorcontrib>JOSÉ ENRIQUE MONTERO, CASIMIRO</creatorcontrib><creatorcontrib>ADYS GONZÁLEZ, PALOMO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>AMPARO EMILIA MACÍAS, ABRAHAM</au><au>MARIA DEL CARMEN BARROSO, ALVAREZ</au><au>ADRIANA CARR, PEREZ</au><au>KALET LEÓN, MONZÓN</au><au>RANCÉS BLANCO, SANTANA</au><au>JOSÉ ENRIQUE MONTERO, CASIMIRO</au><au>ADYS GONZÁLEZ, PALOMO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>WGFR ve gangliyozid N-glikolil GM3(NeuGcGM3) ifade eden tümörlerin tedavisine yönelik farmasötik bileşimler</title><date>2018-11-21</date><risdate>2018</risdate><abstract>Mevcut buluş habis tümörlerin tedavisine yönelik farmasötik bileşimler ile ilgilidir. Özellikle EGFR ve GM3 N-glikolil gangliyozid ifade eden bu tümörler, bu hedeflere karşı ayrı terapiler ile üretilen terapötik etkiyi arttırmayı hedefler. Buluşun bu farmasötik bileşimleri hedeflerin her birine karşı antikorlar ve/veya aşılar içerir. Ek olarak mevcut buluş bileşimlerinin uygulanmasına yönelik yöntemler ile ilgilidir.
The present invention relates to pharmaceutical compositions for the treatment of malignant tumors. Particularly those tumors that express EGFR and GM3 N- glycolyl ganglioside targets to enhance the therapeutic effect produced by separated therapies against these targets. The pharmaceutical compositions of the invention include antibodies and/or vaccines against each of the targets. Additionally the present invention relates to methods for applying the compositions of the invention.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | tur |
| recordid | cdi_epo_espacenet_TR201816232TT4 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | WGFR ve gangliyozid N-glikolil GM3(NeuGcGM3) ifade eden tümörlerin tedavisine yönelik farmasötik bileşimler |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T00%3A49%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=AMPARO%20EMILIA%20MAC%C3%8DAS,%20ABRAHAM&rft.date=2018-11-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ETR201816232TT4%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |